These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33110390)

  • 21. Modulation of the inflammatory process by statins.
    Crisby M
    Drugs Today (Barc); 2003 Feb; 39(2):137-43. PubMed ID: 12698208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.
    Mo H; Jeter R; Bachmann A; Yount ST; Shen CL; Yeganehjoo H
    Front Pharmacol; 2018; 9():1515. PubMed ID: 30662405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Statins and their pleiotropic effects].
    Galus R; Zandecki Ł; Jóźwiak J; Włodarski K
    Pol Merkur Lekarski; 2008 Jun; 24(144):545-8. PubMed ID: 18702340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals.
    Rosanoff A; Seelig MS
    J Am Coll Nutr; 2004 Oct; 23(5):501S-505S. PubMed ID: 15466951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins as potential therapeutic agents in multiple sclerosis.
    Stüve O; Prod'homme T; Youssef S; Dunn S; Neuhaus O; Weber M; Hartung HP; Steinman L; Zamvil SS
    Curr Neurol Neurosci Rep; 2004 May; 4(3):237-44. PubMed ID: 15102350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of statins in cancer prevention and treatment.
    Stamm JA; Ornstein DL
    Oncology (Williston Park); 2005 May; 19(6):739-50; discussion 753-4. PubMed ID: 15971450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropic effects of statins: A focus on cancer.
    Ahmadi M; Amiri S; Pecic S; Machaj F; Rosik J; Łos MJ; Alizadeh J; Mahdian R; da Silva Rosa SC; Schaafsma D; Shojaei S; Madrakian T; Zeki AA; Ghavami S
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165968. PubMed ID: 32927022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-atherosclerotic actions of HMG-CoA reductase inhibitors].
    Gmiński J; Wojakowski W
    Przegl Lek; 1997; 54(11):782-7. PubMed ID: 9501689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct effects of statins on cells primarily involved in atherosclerosis.
    Chen H; Ikeda U; Shimpo M; Shimada K
    Hypertens Res; 2000 Mar; 23(2):187-92. PubMed ID: 10770267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins and the Brain: More than Lipid Lowering Agents?
    Fracassi A; Marangoni M; Rosso P; Pallottini V; Fioramonti M; Siteni S; Segatto M
    Curr Neuropharmacol; 2019; 17(1):59-83. PubMed ID: 28676012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
    Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Werner N; Nickenig G; Laufs U
    Basic Res Cardiol; 2002 Mar; 97(2):105-16. PubMed ID: 12002257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel prospects of statins as therapeutic agents in cancer.
    Pisanti S; Picardi P; Ciaglia E; D'Alessandro A; Bifulco M
    Pharmacol Res; 2014 Oct; 88():84-98. PubMed ID: 25009097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
    Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
    Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of statins beyond lipid lowering: potential for clinical benefits.
    Almuti K; Rimawi R; Spevack D; Ostfeld RJ
    Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of statins in inflammation and atherosclerosis.
    Yoshida M
    J Atheroscler Thromb; 2003; 10(3):140-4. PubMed ID: 14564082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pleiotropic Effects of Statins in Endocrine Disorders.
    De La Cruz JA; Mihos CG; Horvath SA; Santana O
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):787-793. PubMed ID: 30924424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
    Zhou Q; Liao JK
    Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
    Manzoni M; Rollini M
    Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.